The pathogenesis of cleidocranial dysplasia (CCD) as well as the specific role of core binding factor β (Cbfβ) and the Runt-related transcription factor (RUNX)/Cbfβ complex in postnatal skeletogenesis remain unclear. We demonstrate that Cbfβ ablation in osteoblast precursors, differentiating chondrocytes, osteoblasts, and odontoblasts via Osterix-Cre, results in severe craniofacial dysplasia, skeletal dysplasia, abnormal teeth, and a phenotype recapitulating the clinical features of CCD. Cbfβ f/f Osterix-Cre mice have fewer proliferative and hypertrophic chondrocytes, fewer osteoblasts, and almost absent trabecular bone, indicating that Cbfβ may maintain trabecular bone formation through its function in hypertrophic chondrocytes and osteoblasts. Cbfβ f/f Collagen, type 1, alpha 1 (Col1α1)-Cre mice show decreased bone mineralization and skeletal deformities, but no radical deformities in teeth, mandibles, or cartilage, indicating that osteoblast lineage-specific ablation of Cbfβ results in milder bone defects and less resemblance to CCD. Activating transcription factor 4 (Atf4) and Osterix protein levels in both mutant mice are dramatically reduced. ChIP assays show that Cbfβ directly associates with the promoter regions of Atf4 and Osterix. Our data further demonstrate that Cbfβ highly up-regulates the expression of Atf4 at the transcriptional regulation level. Overall, our genetic dissection approach revealed that Cbfβ plays an indispensable role in postnatal skeletal development and homeostasis in various skeletal cell types, at least partially by up-regulating the expression of Atf4 and Osterix. It also revealed that CCD may result from functional defects of the Runx2/Cbfβ heterodimeric complex in various skeletal cells. These insights into the role of Cbfβ in postnatal skeletogenesis and CCD pathogenesis may assist in the development of new therapies for CCD and osteoporosis.
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osteoblast differentiation | chondrocyte differentiation | ossification | growth plate formation | endochondral bone formation C ore binding factor (Cbf) plays crucial roles during skeletal development and hematopoiesis. Cbf consists of two subunits: Cbf alpha (Cbfα) and Cbf beta (Cbfβ). Runt-related transcription factor 2 (Runx2) has been shown to be critical for the differentiation of osteoblasts and skeletal development. Cleidocranial dysplasia (CCD) mainly stems from Runx2 deficiency and is characterized by hypoplastic/aplastic clavicles, patent fontanelles, supernumerary teeth, and short stature (1) (2) (3) . Notably, there were two case reports of CCD patients with no RUNX2 mutation involving 16q22 large deletions, suggesting CBFβ haploinsufficiency might be involved in cranial facial defects (4, 5) . Although great progress has been made toward understanding the function of Runx2 and Cbfβ during the past 20 y, their function in postnatal skeletogenesis and in the pathogenesis of related diseases (e.g., CCD) still remains unclear.
Runx2-I/Cbfβ and Runx2-II/Cbfβ double transgenic mice had enhanced inhibition of osteoblast maturation, resulting in severe osteopenia and fragility in adult mice (6) . There is a lack of genetic evidence establishing a specific effect of the missing Runx2/Cbfβ complex in postnatal skeletogenesis and the pathogenesis of CCD due to the fact that Runx2 −/− mice die at birth and Cbfβ −/− mice die at midgestation (7, 8) and Cbfβ GFP/GFP knock-in mice and transgenic rescued Runx2 −/− mice [Cbfβ −/− Tg(Tek-GFP/ Cbfb mice and Cbfβ −/− Tg(Gata1/Cbfb) mice] die soon after birth (9) (10) (11) . To investigate the role of Cbfβ in postnatal skeletal development and the pathogenesis of CCD, we used Osterix-Cre (Osx-Cre) mice, which specifically delete Cbfβ flanked by loxP (Cbfβ f/f ) in osteoblast precursors, differentiating chondrocytes, osteoblasts, and odontoblasts (12, 13) , and Col1α1-Cre mice, which specifically delete Cbfβ in the osteoblast lineage (14) . In this study, through the powerful approach of conditional knockout (cKO) for genetic dissection, we are able to provide unique insight into the pathogenesis of CCD and reveal multiple functions of Cbfβ required for skeletal development.
Results

Cbfβ
f/f Osx-Cre Mice Have Decreased Ossification and Skeletal
Deformities, Resulting in a CCD-Like Phenotype. Cbfβ f/f Osx-Cre mice survived into adulthood, but the homozygote mice displayed severe postnatal skeletal defects. Three-wk-old Cbfβ f/f Osx-Cre mice were of a dispoportionately short stature compared with their wild-type (WT) cohorts (Fig. 1A) . X-ray analysis of femurs from 3-wk-old Cbfβ f/f Osx-Cre mice showed decreased growth and
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Cleidocranial dysplasia (CCD) is a hereditary human skeletal disease. Mutations in Runt-related transcription factor 2, which functions as a heterodimer with core binding factor β (Cbfβ), are found in most individuals with CCD. It has been suspected that Cbfβ may be responsible for other CCD cases. The pathogenesis of CCD and the role of Cbfβ in postnatal skeletogenesis remain unclear. There has been no animal model to study this disease. We demonstrate that ablation of Cbfβ in various skeletal cells results in severe craniofacial and skeletal dysplasia with the phenotype recapitulating clinical features of CCD. The findings from this study of Cbfβ in the skeleton provide insight into the role of Cbfβ in postnatal skeletogenesis and pathogenesis of CCD, which may assist in developing new therapies for CCD and osteoporosis.
Author contributions: W.C. and Y.-P.L. designed research; W.C., J.M., G.Z., and F.T. performed research; W.C., J.M., G.Z., J.J., M.W., M.M., F.T., C.P., X.Z., L.W., and Y.-P.L. analyzed data; and W.C., J.J., C.P., and Y.-P.L. wrote the paper. reduced ossification (Fig. 1B) . Cbfβ f/f Osx-Cre mice also exhibited underdeveloped mandibles and mandibular retrognathism, resulting in a large gap inside the oral cavity and causing an anterior open bite, and severely affected teeth (Fig. 1C) . X-ray analysis revealed hypoplasia/aplasia of clavicles and underdeveloped long bones, leading to severe deformities in the mutant mice (Fig. 1D) . These skeletal defects persisted in 3-and 10-wk-old Cbfβ f/f Osx-Cre mice (Fig. S1 ). Classical CCD is caused by RUNX2 haploinsufficiency. Our results showed that there was a milder CCD phenotype in Cbfβ cKO heterozygous mice and a more severe CCD phenotype in Cbfβ cKO homozygous mice (Fig. S1E ). Microcomputed tomography (μCT) scan of femurs revealed a drastic decrease in bone density and an almost complete lack of trabecular bone in the mutant mice ( Fig. 1 E and F) . Moreover, incisors were completely absent (Fig. 1G , middle mouse) or severely underdeveloped in 17-d-old Cbfβ f/f Osx-Cre mice (Fig. 1G , right mouse). Higher magnification further illustrated the underdeveloped incisors (Fig. 1H ) and underdeveloped molars in Cbfβ f/f Osx-Cre mice (Fig. 1I) . The teeth defects were still apparent in 10-wk old mutant mice, which also exhibited a supernumerary teeth-like phenotype, a clinical feature of CCD (Fig. 1J) . The genotypes of the mice were confirmed by PCR (Fig. 1K ) from tail snip DNA. These results showed that Cbfβ ablation in osteoblast precursors results in many clinical features of CCD, including short stature, hypoplastic/aplastic clavicles, and dental anomalies. Cbfβ f/f Osx-Cre mice was severely underdeveloped (Fig. 2A) . However, some bones showed greater defects than other bones. The skull, calveria, and mandible were not only undercalcified in the mutant mice, but also displayed patent fontanelles (Fig. 2B) . Moreover, the forelimbs (Fig. 2C) and clavicles ( Fig. 2D) were severely affected in the mutant mice, whereas, again, the vertebrae were largely unaffected (Fig. 2E) . The mandibula, hyoid bone, thyroid cartilage, and cricoid cartilage in the newborn Cbfβ f/f Osx-Cre mice were also underdeveloped due to decreased ossification (Fig. S2) . Further, the underdevelopment of the hyoid bone was still apparent in 6-d-old Cbfβ f/f Osx-Cre mice. Overall, the skeleton of the mutant mice was severely underdeveloped compared with normal littermates. The data suggest that the process of bone ossification was delayed in mutant mice. Notably, Cbfβ f/f Osx-Cre mice had patent fontanelles, another common characteristic of CCD. Fig. 3 A and B) . Newborn Cbfβ f/f Osx-Cre mice had decreased cartilage and underdeveloped growth zones, which may partially stem from the reduction in chondrocytes of the hypertrophic region of the growth plate in mutant mice (Fig. 3 A-C) . Furthermore, we found that the columns of proliferating and hypertrophic chondrocytes were less organized in Cbfβ f/f Osx-Cre mice (Fig. 3C) . We also found a decrease in intramembranous bone formation in Cbfβ f/f Osx-Cre mice as assessed by H&E staining (Fig. 3D) . Finally, Von Kossa and Fast red staining revealed a substantial decrease in calcium and a significantly shorter medullary cavity in 10-wk-old Cbfβ f/f Osx-Cre mice compared with control mice (Fig. 3E) . Collectively, these results demonstrate that Cbfβ f/f Osx-Cre mice survive to adulthood and recapitulate the clinical features of CCD. Goldner's Trichrome Osx-Cre mice (Fig. 3G ), but the number of osteoclasts was not significantly affected (Fig. 3G) . The tartrateresistant acid phosphatase staining confirmed that the number of osteoclasts was not significantly affected in Cbfβ f/f Osx-Cre mice (Fig. S3A ). Goldner's Trichrome staining also showed that there was a significant decrease in bone volume and fewer osteoblasts ( or Cartilage. Because Cbfβ f/f Osx-Cre mice delete the Cbfβ gene in both osteoblasts and hypertrophic chondrocytes, we generated Cbfβ f/f Col1α1-Cre mice to observe the impact of Cbfβ specifically in the osteoblast lineage during postnatal bone development (Fig. 4) . Similar to the Cbfβ f/f Osx-Cre mice ( Fig. 1) , bone formation was severely inhibited in Cbfβ f/f Col1α1-Cre mice, leading to shorter stature and decreased bone density compared with WT mice (Fig. 4 A-C). Unlike Cbfβ f/f Osx-cre mice ( Fig. 1 ), the clavicle (Fig. 4B ), mandibles and teeth (Fig. 4D) , and intramembranous bone formation (Fig. 4E) were not dramatically affected in Cbfβ f/f Col1α1-Cre mice. Safranin O staining revealed that there is a shortened growth plate, a decreased and disorganized proliferative zone, and a lack of hypertrophic chondrocytes in Cbfβ f/f Osx-Cre mutant mice (Fig. 4F) . However, the growth plate development in Cbfβ f/f Col1α1-Cre mutant mice is normal compared with the WT mice control (Fig. 4G ).
Cbfβ Deficiency Affects Chondrocyte Proliferation and Maturation in Cbfβ f/f
Osx-Cre Mice. Further examination of the impact of the Cbfβ deletion in chondrocytes through proliferating cell nuclear antigen (PCNA) staining revealed that there is a reduction in proliferative chondrocytes in both the resting and proliferation zones of the Cbfβ f/f Osx-Cre but not in the Cbfβ f/f Col1α1-Cre mice (Fig. 5A ). This is due to the fact that Cbfβ f/f Osx-Cre mice excise the Cbfβ gene in odontoblasts, osteoblasts, and chondrocytes, whereas Cbfβ f/f Col1α1-Cre mice only delete Cbfβ in the osteoblast lineage. Importantly, this finding indicates that Cbfβ is required for chondrocyte differentiation and the subsequent growth plate formation during postnatal skeletal development. As several studies indicate that Cbfβ interacts with Runx1, Runx2, and Runx3 during skeletal development, we examined whether the Cbfβ deficiency affected the expression of Runx1, Runx2, and Runx3. Immunohistochemistry analysis showed that there is a reduction in the expression of Osx and Cbfβ in Cbfβ f/f
Osx-Cre and Cbfβ f/f Col1α1-Cre mice but that Cbfβ deletion did not affect the level of Runx2 expression (Fig. 5B) . Immunostaining analysis of newborn Cbfβ f/f Osx-Cre and WT mice femur showed that Runx1 expression was mainly detected in the proliferative zone, Runx2 expression was mainly detected in the hypertrophic zone, and Runx3 expression was mainly detected in hypertrophic and prehypertrophic chondrocytes (Fig. S4 A-C) . Interestingly, expression of Runx1, Runx2, and Runx 3 showed no variation between WT and mutant mice (Fig. S4 A-C) . Immunostaining analysis of newborn mice showed a drastic reduction in the expression of Collagen X (ColX), which is a marker of hypertrophic chondrocytes, in the growth plates of Cbfβ f/f Osx-Cre mice (Fig. 5C ). These results demonstrate that chondrocyte proliferation and maturation are dependent on Cbfβ's function. Osx-Cre was characterized by Von Kossa staining after 21 d of culture (Fig. 6A) . GeneChip analysis indicated that Atf4 mRNA expression in mouse C57/BL6 WT calvarial cells on day 7 and day 21 of osteoblastogenesis is similar to that of secreted phosphoprotein 1 (Spp1), ALP liver/bone/kidney (Alpl), and Col1α1, whereas osteocalcin (OCN) has mRNA expression levels that were much higher (Fig. 6B) . Further microarray data analysis revealed that Atf4 mRNA expression in mouse calvarial cells increased more than 10-fold on culture day 21 (Fig. 6B) . The dramatic changes in Atf4 mRNA expression were confirmed by quantitative RT-PCR using Cbfβ f/f Osx-Cre, Cbfβ f/f Col1α1-Cre, and WT mouse calvarial cells during osteoblastogenesis (Fig. 6C, Fig. S5 B and C, and Fig. S6 ). Western blot was used 
Cbfβ deficiency reduced the expression of Cbfβ, Osx, Col1α1, and Atf4, but not Runx2 (Fig. 6D) . In contrast, the expression of SRY (sex determining region Y)-box 9 (Sox9) was increased in Cbfβ-deficient calvaria-derived osteoblasts (Fig.  6D) . Taken together, these results demonstrate that Cbfβ deletion impacts chondrocyte and osteoblast differentiation by affecting the expression of critical downstream genes at the mRNA level. Notably, on day 14, Cbfβ f/f Osx-Cre calvarial cells still expressed some Col1α1 and Spp1 but not OCN (Fig. 6E) . These data indicate that osteoblasts generated from Cbfβ f/f Osx-Cre mice were maintained in an immature stage and prevented from differentiation into mature osteoblasts, which are critical for bone formation.
Cbfβ Up-Regulates Osterix and Atf4 Expression Directly by Associating with Their Promoters. To determine if the Runx/Cbfβ complex binds to Osx, Runx2, and Atf4 promoters, chromatin immunoprecipitation (ChIP) assay was performed. We analyzed the respective promoter regions and designed primers accordingly. We found several Runx binding sites in the Osx promoter region (-3000/+80), Runx2 promoter region (-3000/+80), and Atf4 promoter region (-4000/+80) (Fig. S7) . ChIP analysis was performed using the anti-Cbfβ antibody, and the DNA was pulled down, amplified, and analyzed using primers as shown in Fig. S7 . The ChIP input value using each primer represents the binding efficiency of an adjacent region around the location of the primer pair. We found that Osx primer 4b resulted in the highest value, indicating that Runx binding sites 13-15 in the Osx promoter region should be the most efficient (Fig. 7A) . (Fig. 7 B and C) . The promoter luciferase assay showed that luciferase activity driven by Atf4 promoters is very low in the absence of Cbfβ (Fig. S8) . Luciferase activity was highest when driven by the longest Atf4 promoter fragment (-4051/+80) and less high when driven by the Atf4 promoter fragments (-3109/+80 and -1676/+80) in WT cells, but not in the mutant cells. Interestingly, about 70% of the full Luciferase activity driven by the longest Atf4 promoter fragment (-4051/+80) still remains with the Atf4 promoter fragment (-500/+80) in WT cells, but not in the mutant cells. This indicates that the Atf4 promoter region (-500/+80) containing Runx binding sites 5-7 is critical for Cbfβ regulation of Atf4 gene expression (Figs. S7 and  S8) . Consistently, the primer 3a amplifying regions near Runx binding sites 5-7 in the Atf4 promoter gave out the highest value in ChIP assays (Fig. 7C) , indicating that the Cbfβ/RUNX complex may bind Runx binding sites 5-7 to up-regulate Atf4 gene expression. There was also a decrease in luciferase expression driven by the Runx2 promoter (-1580/+80 and -900/+80) in the absence of Cbfβ. However, Runx2 expression does not vary between WT and mutant cells (Fig. 7D and Fig. S6A ). This indicates that there may be some other mechanism driving the steady expression of Runx2 in Cbfβ knockout mice and cells, probably working on a distant end of the Runx2 promoter (before -1580). In conclusion, we believe that Cbfβ directly associates with the Osx and Atf4 promoter regions and regulates their expression. To confirm these Western and real-time RT-PCR results in calvarial culture experiments, we used protein directly isolated from calvaria ( Fig. 7D and Fig. S6 ). The Western blot result is consistent with that from the calvarial culture experiment result (Fig. 6D and Fig. 7D ). Osx-Cre cKO mice and that Cbfβ f/f Osx-Cre mice exhibit a CCD-like phenotype (Fig. 1) supports the notion that CCD may result from a functional defect of the Runx2/Cbfβ heterodimeric complex in various cell types. It also indicates that, in terms of the pathogenesis of CCD, Cbfβ deficiency may be equivalent to RUNX2 haploinsufficiency as it relates to the function of the Runx2/Cbfβ complex in skeletogenesis.
Indispensable Role of Hypertrophic Chondrocytes in Endochondral
Bone Formation. The role of hypertrophic chondrocytes in endochondral bone formation is a long-standing question. Our results showed that there is a shortened growth plate, a decreased and disorganized proliferative zone, and a reduction in hypertrophic chondrocytes in Cbfβ f/f Osx-Cre mutant mice. However, growth plate development in Cbfβ f/f Col1α1-Cre mutant mice is normal compared with the WT control. These phenotypes of the mutant mice provided a unique opportunity to address the role of hypertrophic chondrocytes in endochondral bone formation. Our results indicate that Cbfβ maintains trabecular bone formation through its function in chondrocytes. Based on the severe endochondral bone defects in Cbfβ f/f Osx-Cre mutant mice (Figs. 1 and 3 ) and the mild endochondral bone defects in Cbfβ f/f Col1α1-Cre mutant mice (Fig. 4) , we conclude that the role of hypertrophic chondrocytes in endochondral bone formation is indispensable. We hypothesize that the lack of trabecular bone is not the result of a lack of osteoblast precursors and preosteoblasts but may be a result of a lack of the factor(s) (such as Ihh) secreted by prehypertrophic or hypertrophic chondrocytes, although the mechanism of this dependence remains to be identified.
Cbfβ Plays an Indispensable Role in Postnatal Skeletal Development and Homeostasis by Up-Regulating the Expression of Atf4 and Osterix.
Cbfβ deficiency reduced the expression of several key factors that mediate osteoblast formation and/or function (e.g., Osx and Atf4). This suggests that Cbfβ may have a role in promoting the commitment of osteoblast precursors into the osteoblast lineage. Yang et al. reported that ATF4 is a critical regulator of osteoblast differentiation and function (15) . However, how ATF4 is regulated at the transcriptional regulation level remains unclear. Our study shows that Cbfβ associates with the promoter regions of Osx and Atf4 and highly up-regulates the expression of Atf4 at the transcriptional regulation level as shown by ChIP assay, microarray analysis, quantitative PCR (qPCR) analysis, and promoter reporter assay. We also found that Cbfβ is crucial for the later stages of chondrocyte differentiation as its deletion affects chondrocyte maturation and the formation of the growth plate. Because Runx2 functions as a heterodimer with CBFβ, it has been suspected that Cbfβ may be responsible for some cases of CCD. Although no CBFβ mutation has yet been identified in classical CCD patients, our Cbfβ f/f Osx-Cre mouse models support the notion that search genetic alterations in the CBFβ gene may be responsible for CCD in those patients with no RUNX2 mutation. Our results are in agreement with that of previous studies reporting that Runx2 deficiency causes an arrest in tooth development (16) and that Osx is necessary for odontoblast differentiation (13) . These findings provide great insight into the pathogenesis of CCD and the role of Cbfβ in both postnatal skeletal and tooth development. The insights resulting from this study may assist in the development of novel treatments for CCD and other bone diseases.
Materials and Methods
Animal Experimentation and Generation of Cbfβ cKO Mice. Cbfβ f/f mice (Jackson Laboratory, strain name B6.129P2-Cbfβ tm1Itan /J) were crossed with skeletal tissue cell (including osteoblast precursors, osteoblasts, chondrocytes, and odontoblasts)-specific Osx-cre mice (12) [Tg(Sp7-tTA,tetO-EGFP/cre)1Amc, Mouse Genome Informatics] or osteoblast-specific Col1α1-Cre mice. Their progeny were crossed with Cbfβ f/f mice to obtain Cbfβ f/f Col1α1-Cre mice or Cbfβ f/f Osx-Cre mice. In our study, we only use one copy of Osx-Cre (Cbfβ
Osx-Cre/+) in the cKO mutation. We used Cbfβ f/f mice and Osx-Cre/+ mice as controls. Mouse C57/BL6 WT calvarial cells were also used. All research procedures using mice were approved by the University of Alabama at Birmingham (UAB) Animal Care and Use Committee and conformed to the National Institutes of Health guidelines.
Skeletal Analysis, Tissue Preparation, and Histology Stains. Histomorphometric samples were processed as nondecalcified hard-tissue sections. Bone parameters were quantified via 6 μm sections obtained from 3-wk-old mice. For paraffin sections, samples were decalcified and dehydrated in ethanol, cleared in xylene, embedded in paraffin, and sectioned at 6 μm with Leica microtome and mounted on Superfrost Plus slides (Fisher). Histological analysis was performed including staining with Alcian blue, safranin O, and H&E using paraffin sections.
ChIP and Promoter Analyses. Cells were derived from calvaria of newborn WT mice and mutant mice. Osx, Runx2, and Atf4 promoter sequences were analyzed for putative Runx binding sites with PROMO3.0 (http://alggen.lsi. upc.es/) using version 8.3 of the TRANSFAC database. ChIP was performed using monoclonal anti-Cbfβ antibody (sc-20693X) and DNA extraction, and qPCR was performed. The Osx, Runx2, and Atf4 promoters were amplified using PCR from BAC clones provided by the BACPAC Resource Center at Children's Hospital Oakland Research Institute. These amplified fragments were cleaved and ligated into the pGL3 vector from Promega. The calvarial cells were cotransfected with each construct with the amount of 100 ng per well as well as pSV-β-galactosidase construct with the amount of 50 ng per well (Promega) and incubated for 6-8 h. The culture medium was replaced with osteogenic medium and cultured for 2 d. Luciferase activity was measured using a Steady-Glo luciferase assay system (Promega cat. no. E2510). pSV-β-galactosidase activity was measured using a β-galactosidase Enzyme Assay system (Promega cat. no. E2000).
Statistical Analysis. All data are presented as the mean ± SD (n ≧ 6). Statistical significance was assessed using Student t test. P values < 0.05 were considered significant. Data are expressed as mean ± SD, n ≧ 6, *P < 0.05, **P < 0.01, ***P < 0.001. The results are representative of at least four individual experiments. The analyses of the data were performed with the SPSS 16.0 software (SPSS Incorporation). Please see SI Materials and Methods for additional details.
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Osx
Cre/+ mice were generated by crossing Cbfβ f/f mice and Cbfβ f/+ mice with Osx Cre/+ mice and Cbfβ f/f mice as the control. We did not find any delayed cortical bone growth or any other skeletal defect in the control mice.
Radiographic Procedures. For X-ray analysis, radiography was performed using the Faxitron Model MX-20 at 26 kV by the University of Alabama at Birmingham (UAB) Small Animal Bone Phenotyping Core associated with the Center for Metabolic Bone Disease. The microcomputed tomography analysis was performed to determine the bone mass of fixed femurs by the UAB Small Animal Bone Phenotyping Core associated with the Center for Metabolic Bone Disease.
Histomorphometric Analysis. Histomorphometric samples were processed as nondecalcified hard-tissue sections as described (1) . Bone parameters were quantified via 6 μm sections obtained from 3-wk-old mice.
Skeletal Analysis. For skeletal preparations, mice were skinned, eviscerated, fixed in 95% (vol/vol) ethanol, cleared in acetone, stained with Alizarin red and/or Alcian blue stains, and sequentially cleared in 1% KOH. Cartilage and mineralized bone were characterized by different colors (blue and red, respectively) after the stain, according to standard protocols (2).
Tissue Preparation and Histology Stains. Femurs and tibiae of mice were harvested, skinned, and fixed in 4% (wt/vol) paraformaldehyde overnight. Samples were then dehydrated in ethanol solution and decalcified in 10% (wt/vol) EDTA for 1-4 wk. For paraffin sections, samples were dehydrated in ethanol, cleared in xylene, embedded in paraffin, and sectioned at 6 μm with Leica microtome and mounted on Superfrost Plus slides (Fisher).
For frozen sections, samples were infiltrated in 30% (wt/vol) sucrose, embedded in optimal cutting temperature compound, sectioned at 8 μm with a freezing microtome, and affixed to Superfrost Plus Gold slides (Fisher). Histological analysis was performed including staining with Alcian blue, safranin O, hematoxylin/eosin (H&E) (3), and Goldner's trichrome stains (4) using paraffin sections. -free PBS and then fixed on slides in 10% (vol/vol) cold Neutral Formalin solution. We then added 2.5% (wt/vol) silver nitrate solution, and the slides were incubated under UV light for 5-10 min. After incubation, the unincorporated silver nitrate was removed by washing with 5% (wt/vol) sodium thiosulfate.
Proliferation Assay. To detect proliferating cells in culture, immunochemistry staining was performed according to the manufacturer's instructions. Horseradish peroxidase-conjugated proliferating cell nuclear antigen (PCNA) antibodies (cat. no.
93-1143; Zymed Laboratories Inc.) and Vector DAB substrate (3,3′-diaminobenzidine) kits (cat. no. SK-4100; Vector Laboratories) were used.
Immunohistochemistry. For immunohistochemistry, samples were embedded in paraffin and sectioned as described previously. The Vector DAB substrate kit (cat. no. SK-4100; Vector Laboratories) was used along with secondary staining kits for mouse (on mouse) and rabbit (cat. no. BMK-2202 and PK-6101, respectively; Vector Laboratories) and primary antibodies for Osterix (ab22552; Abcam), Runt-related transcription factor 2 (RUNX2) (ab23981; Abcam), and Cbfβ (sc-56751; Santa Cruz).
Immunofluorescence. Samples were embedded in tissue freezing medium, and sections were cut at a thickness of 8 μm with a cryotome. Pictures were taken by Leica confocal microscopes (SP1) and a Zeiss fluorescent microscope (Zeiss Axio Imager). The following antibodies were used: rabbit anti-Col10 (1:200; ab58632, Abcam), anti-Runx1 (ab35962, Abcam), Runx2 (pc-287, Merck/Millipore), and Runx3 (sc-30197, Santa Cruz).
Primary Cell Culture. Calvarial cells were isolated from newborn mice and seeded in cell culture dishes at a density of 3 × 10 3 cells/cm 2 as previously described (5) . After growing to confluence, cells were induced to differentiate into osteoblasts using osteogenic medium and BGJb medium (Gibco, 12591) supplemented with 10% (vol/vol) FBS, 50 μg/mL L-ascorbic acid (Sigma, A4544), and 5 mM β-glycerolphosphate (Sigma, G9891). Osteoblastogenesis was analyzed by alkaline phosphatase (ALP) staining according to the manufacturer's manual (sigma, A2356) on day 14. Osteoblast mineralization was examined by Von Kossa staining on day 21.
GeneChip Analysis. We analyzed independently prepared duplicate samples containing primary osteoblasts derived from the calvarial bone of C57/BL6 wild-type (WT) mice as previously described (3). TRIzol reagent (Life Technologies) was used according to the manufacturer's protocol to extract total RNA from C57/BL6 WT calvarial cells after culturing for 7 or 21 d. RNA profiling was performed by using the Affymetrix mouse 430 Plus 2.0 array as described (6) . Replicate samples were averaged for reporting.
Promoter Analyses. To determine 5′-flanking regulatory activity, calvarial cells were cultured for 5 d in osteogenic medium, reseeded on 96-well plates, and transfected with constructs ( Fig.  S8 ) using Fugene6 reagent (Roche) as described (4) . The calvarial cells were cotransfected with each construct (Fig. S8) with the amount of 100 ng per well as well as pSV-β-galactosidase construct (Promega) (50 ng/well) and incubated for 3 h as described (4, 7). The culture medium was replaced with osteogenic medium and cultured for 2 d. Luciferase activity was measured using a Steady-Glo luciferase assay system (Promega). PGL3 basic reporter vectors were used as controls (Promega). Luminescence was detected with a luminometer (BioTek Synergy 2). The luciferase activity in transfected cultures was standardized by normalization to β-galactosidase activity, and the protein concentration of cell extracts was determined using a protein assay kit (BioRad) as described (4, 7) . In all experiments, constructs are tested in triplicate.
Quantitative Real-Time PCR Analysis. mRNA was extracted from cultured cells on days 7, 14, and 21 using TRIzol (Invitrogen) and then reverse-transcribed into cDNA according to the manu- Cbfβ f/f Col1α1-cre mice had a significant reduction in trabecular bone and osteoblast numbers but not in osteoclast numbers. Data are expressed as mean ± SD, n ≧ 6, *P < 0.05. The results demonstrate that deletion of Cbfβ affects osteoblastogenesis in part by affecting the expression of osteoblast and chondrocyte genes. Data are normalized to the housekeeping gene, hypoxanthine-guanine phosphoribosyl transferase. Results are expressed as mean ± SD, n ≧ 6 in each group. *P < 0.05, **P < 0.01. (Fig. 7D) , normalized to β-tubulin from the calvaria of Cbfβ f/f Osx-Cre, Cbfβ f/f Col1α1-Cre, and WT mice. (B) mRNA expression levels of Cbfβ, Runx1, Runx2, Runx3, Opn, Sox9, Atf4, and Osx in calvarial cells from Cbfβ f/f Osx-Cre, Cbfβ f/f Col1α1-Cre, and WT mice were determined by qRT-PCR after culturing in the osteoblast differentiation media for 14 d. Data were normalized to Gapdh. Results are expressed as means ± SD, n ≥ 6 in each group. *P < 0.05, **P < 0.001. Runx2 promoter fragments were inserted into the pGL3-basic vector. Calvarial cells were transfected with pGL3-control, pGL3-Runx2-1,580 bp, or pGL3-Runx2-900 bp. Luciferase was detected 48 h posttransfection. The signal was normalized to β-gal activity. (B) Atf4 promoter fragments were inserted into the pGL3-basic vector. Calvarial cells were transfected with pGL3-control, pGL3-Atf4-4,051 bp, pGL3-Atf4-3,109 bp, pGL3-ATF4-1,676 bp, or pGL3-ATF4-500 bp. β-gal expression plasmids were cotransfected as control. Luciferase was detected 48 h posttransfection. The signal was normalized to β-gal activity. Results are presented as mean ± SD, n ≧ 6 in each group. *P < 0.05, **P < 0.01, ***P < 0.005.
